Thoratec, LLC

Waltham, MA 02451

Market Performance

NASDAQ: THOR
52 Week High $63.51
52 Week Low $25.04

SBIR Award Summary

Total Number of Awards 5
Total Value of Awards $4.07MM
First Award Date 04/01/09
Most Recent Award Date 07/01/11

Key Personnel

Last Name Name Awards Contact
Dasse Kurt A Dasse 2
Gellman Barry N Gellman 3

5 Awards Won

Phase 2 SBIR

Agency: Department of Health & Human Services
Topic: PA-08-050
Budget: 07/01/11 - 06/30/12

DESCRIPTION (provided by applicant): The objective of this research plan is to transition the development of the UltraMag ventricular assist system, which is designed to support neonates and small children, from the preclinical to the clinical trial phase. The work will culminate in a single center, prospective, nonrandomized, open-label, clinic...

Phase 2 SBIR

Agency: Department of Health & Human Services
Topic: PA-08-050
Budget: 07/01/10 - 06/30/11

DESCRIPTION (provided by applicant): The objective of this research plan is to transition the development of the UltraMag ventricular assist system, which is designed to support neonates and small children, from the preclinical to the clinical trial phase. The work will culminate in a single center, prospective, nonrandomized, open-label, clinic...

Phase 2 SBIR

Agency: Department of Health & Human Services
Topic: PA-08-050
Budget: 09/01/09 - 06/30/10

DESCRIPTION (provided by applicant): The objective of this research plan is to transition the development of the UltraMag ventricular assist system, which is designed to support neonates and small children, from the preclinical to the clinical trial phase. The work will culminate in a single center, prospective, nonrandomized, open-label, clinic...

Phase 2 SBIR

Agency: Department of Health & Human Services
Topic: PA-06-120
Budget: 07/01/09 - 12/31/11

DESCRIPTION (provided by applicant): The objective of this work is to transition the development of a ventricular assist system designed to support neonates and small children from animal testing into a single center clinical trial. The 2001 report of the NHLBI) sponsored Task Force on Research in Pediatric Cardiovascular Disease identified the ...

Phase 2 STTR

Agency: Department of Health & Human Services
Topic: PA-07-281
Budget: 04/01/09 - 03/31/12

DESCRIPTION (provided by applicant): Chronic lung disease remains America's third largest cause of death. Adult respiratory distress syndrome (ARDS) alone afflicts approximately 150,000 patients every year with a mortality rate between 30-70%. Current therapy for respiratory failure includes mechanical ventilation and extracorporeal membrane oxy...